Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2025-12-25 @ 2:48 AM
NCT ID:
NCT01511133
Eligibility Criteria:
Inclusion criteria:
* Subjects enrolled previously in randomized, double-blind and placebo-controlled studies 444563/022 (NCT00263666), 444563/033 (NCT00757770), 103477 (NCT00169455), and 104480 (NCT00137930);
* Infants aged 6 to 12 weeks at Dose 1 vaccinated with either HRV vaccine or placebo;
* Infants for whom sufficient residual volume of the stool samples at predetermined time points is available;
* Infants for whom sufficient residual volume of the pre and post vaccination blood samples is available.
Exclusion criteria:
\- Not applicable
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Weeks
Maximum Age:
12 Weeks
Study:
NCT01511133
Study Brief:
Protocol Section:
NCT01511133